Yinglu Zhou
8PUBLICATIONS
68CO-AUTHORS
Get your video featured.
Publish with JoVEGet your video featured.
Publish with JoVE
Publications (8)
Sort by Publication Date:
|Mar 27, 2026
Mirvetuximab soravtansine plus pembrolizumab in recurrent folate receptor alpha-positive uterine serous carcinoma: a phase II trial.Rebecca L Porter, Yinglu Zhou, Nebiyat Eskndir
|Apr 03, 2025
Characteristics and outcomes of patients with double refractory and double exposed chronic lymphocytic leukemia.James T Yoon, Yinglu Zhou, Mariia Mikhaleva
|Jan 01, 2024
Five-year follow-up of a phase 2 study of ibrutinib plus fludarabine, cyclophosphamide, and rituximab as initial therapy in CLL.Inhye E Ahn, Danielle M Brander, Yue Ren
|Feb 24, 2023
Rewiring of the N-Glycome with prostate cancer progression and therapy resistance.William Butler, Colin McDowell, Qing Yang
|Jan 30, 2023
A phase 1b study of ibrutinib in combination with obinutuzumab in patients with relapsed or refractory chronic lymphocytic leukemia.Christine E Ryan, Danielle M Brander, Paul M Barr
|Dec 13, 2022
The Prostate Stromal Transcriptome in Aggressive and Lethal Prostate Cancer.Chaoran Ma, Yinglu Zhou, Giuseppe Nicolò Fanelli
Pageof 2
Frequent Collaborators
3 joint publications
Svitlana Tyekucheva
3 joint publications
Jennifer R Brown
2 joint publications
Jiaoti Huang
2 joint publications
David C Fisher
2 joint publications
Ann S LaCasce
2 joint publications
Andrew J Armstrong
2 joint publications
Matthew S Davids
2 joint publications
Owen N Witte
2 joint publications
Qing Yang
1 joint publications
Panagiotis A Konstantinopoulos
